0 382

Cited 5 times in

Rheumatoid factor positivity in antineutrophil cytoplasmic antibody-associated vasculitis: a distinct clinical entity or innocent bystander?

DC Field Value Language
dc.contributor.author박용범-
dc.contributor.author안성수-
dc.contributor.author이상원-
dc.contributor.author하장우-
dc.date.accessioned2022-05-09T17:11:56Z-
dc.date.available2022-05-09T17:11:56Z-
dc.date.issued2022-04-
dc.identifier.issn1462-0324-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/188433-
dc.description.abstractObjective: To investigate the significance of RF positivity in ANCA-associated vasculitis (AAV) patients. Methods: AAV patients were divided into groups as follows: RF (+)/ANCA (+) (n = 94), RF (-)/ANCA (+) (n = 80), RF (+)/ANCA (-) (n = 15) and RF (-)/ANCA (-) (n = 25). Their clinical data, organ involvement patterns, laboratory data, and patient outcomes were assessed. Kaplan-Meier analysis and propensity score matching (PSM) were performed to compare outcomes and analyse differences between the groups. Results: Of the 214 patients, RF and ANCA positivity was found in 109 (50.9%) and 174 (81.3%) patients, respectively. RF (+)/ANCA (+) patients more frequently presented with general manifestations (58.5%) than the other groups. Additionally, compared with those of RF (-)/ANCA (+) group, RF (+)/ANCA (+) patients were older, had higher white blood cell, neutrophil, platelet counts and acute phase reactants; however, creatinine and albumin levels were lower. The end-stage kidney disease-free survival rate was significantly higher in the RF (+)/ANCA (+) group (P =0.013), while the proportion of renal involvement was comparable to the RF (-)/ANCA (+) group. PSM showed no difference in patient outcomes between the two groups after adjustment. Conclusion: RF positivity was associated with a distinct phenotype in AAV patients. In particular, difference was observed in clinical features and outcomes between RF (+)/ANCA (+) and RF (-)/ANCA (+) groups, although the direct prognostic implication of RF was not evident.-
dc.description.statementOfResponsibilityrestriction-
dc.languageEnglish-
dc.publisherOxford University Press-
dc.relation.isPartOfRHEUMATOLOGY-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.subject.MESHAnti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis* / complications-
dc.subject.MESHAntibodies, Antineutrophil Cytoplasmic-
dc.subject.MESHHumans-
dc.subject.MESHKidney Failure, Chronic* / complications-
dc.subject.MESHPrognosis-
dc.subject.MESHRetrospective Studies-
dc.subject.MESHRheumatoid Factor-
dc.titleRheumatoid factor positivity in antineutrophil cytoplasmic antibody-associated vasculitis: a distinct clinical entity or innocent bystander?-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Internal Medicine (내과학교실)-
dc.contributor.googleauthorSung Soo Ahn-
dc.contributor.googleauthorJang Woo Ha-
dc.contributor.googleauthorYong-Beom Park-
dc.contributor.googleauthorSang-Won Lee-
dc.identifier.doi10.1093/rheumatology/keab595-
dc.contributor.localIdA01579-
dc.contributor.localIdA02233-
dc.contributor.localIdA02824-
dc.contributor.localIdA06125-
dc.relation.journalcodeJ03672-
dc.identifier.eissn1462-0332-
dc.identifier.pmid34320628-
dc.identifier.urlhttps://academic.oup.com/rheumatology/article/61/4/1366/6329840?login=false-
dc.subject.keywordantineutrophil cytoplasmic antibody-
dc.subject.keywordend-stage kidney disease-
dc.subject.keywordgeneral manifestation-
dc.subject.keywordprognosis-
dc.subject.keywordrheumatoid factor-
dc.subject.keywordvasculitis-
dc.contributor.alternativeNamePark, Yong Beom-
dc.contributor.affiliatedAuthor박용범-
dc.contributor.affiliatedAuthor안성수-
dc.contributor.affiliatedAuthor이상원-
dc.contributor.affiliatedAuthor하장우-
dc.citation.volume61-
dc.citation.number4-
dc.citation.startPage1366-
dc.citation.endPage1375-
dc.identifier.bibliographicCitationRHEUMATOLOGY, Vol.61(4) : 1366-1375, 2022-04-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.